Clinical Validation of Novel Immunoassays for Plasma Phosphorylated Tau 217, 212, 181, 231, and Brain‐Derived Tau Across the Biochemical Spectrum of Alzheimer's Disease is a research paper published in Journal of Neurochemistry (2025). On theSindex it has a DataRank of 0.165. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Vetenskapsrådet
Grant: #2023‐00356
Vetenskapsrådet
Grant: #2022‐01018
NIA NIH HHS
Grant: R01 AG075336
Swedish Research Council
Grant: #2023-00356
NIA NIH HHS
Grant: R01 AG083874
Swedish Research Council
Grant: #2022-01018
Swedish Research Council
Grant: unidentified
unidentified
FWCI
1.28
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords